SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,580,552 | -8.3% | 93,600 | 0.0% | 0.49% | -4.8% |
Q2 2023 | $2,813,616 | -16.5% | 93,600 | +0.6% | 0.52% | -2.1% |
Q1 2023 | $3,369,390 | -23.8% | 93,000 | -25.0% | 0.53% | -26.5% |
Q4 2022 | $4,423,080 | +5.4% | 124,000 | 0.0% | 0.72% | -0.6% |
Q3 2022 | $4,197,000 | +11.6% | 124,000 | -4.6% | 0.72% | +11.7% |
Q2 2022 | $3,760,000 | +11.9% | 130,000 | +25.0% | 0.65% | -0.8% |
Q1 2022 | $3,361,000 | +10.8% | 104,000 | 0.0% | 0.65% | -2.0% |
Q4 2021 | $3,033,000 | +22.3% | 104,000 | +11.8% | 0.67% | +21.8% |
Q3 2021 | $2,480,000 | -13.4% | 93,000 | 0.0% | 0.55% | -7.8% |
Q2 2021 | $2,863,000 | -24.1% | 93,000 | -35.4% | 0.59% | -23.6% |
Q1 2021 | $3,770,000 | +193.8% | 144,000 | +182.4% | 0.78% | +131.0% |
Q4 2020 | $1,283,000 | +309.9% | 51,000 | +240.0% | 0.34% | +304.8% |
Q3 2020 | $313,000 | -12.1% | 15,000 | 0.0% | 0.08% | -8.8% |
Q2 2020 | $356,000 | +31.9% | 15,000 | 0.0% | 0.09% | +24.7% |
Q1 2020 | $270,000 | -24.2% | 15,000 | 0.0% | 0.07% | -35.4% |
Q4 2019 | $356,000 | -48.2% | 15,000 | -40.0% | 0.11% | -42.1% |
Q3 2019 | $687,000 | -16.9% | 25,000 | 0.0% | 0.20% | -15.6% |
Q2 2019 | $827,000 | -41.0% | 25,000 | -37.5% | 0.23% | -32.7% |
Q1 2019 | $1,402,000 | -35.1% | 40,000 | -38.5% | 0.34% | -34.2% |
Q4 2018 | $2,159,000 | -14.3% | 65,000 | +30.0% | 0.52% | -28.6% |
Q3 2018 | $2,518,000 | -15.8% | 50,000 | 0.0% | 0.73% | -9.3% |
Q2 2018 | $2,992,000 | +30.7% | 50,000 | 0.0% | 0.80% | +27.0% |
Q1 2018 | $2,290,000 | – | 50,000 | – | 0.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
S&T BANK/PA | 223,775 | $8,107 | 1.46% |
Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |